Brahmaputra Biochem Bottling Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
- Paid Up Capital ₹ 2.50 Cr
- Company Age 4 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 18.10 Cr
- Revenue Growth 2133.44%
- Profit Growth -88.05%
- Ebitda 21194.05%
- Net Worth -66.38%
- Total Assets -4.62%
About Brahmaputra Biochem Bottling
Brahmaputra Biochem Bottling Private Limited (BBBPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 November 2020 (Four years and two months 26 days old ). Its registered office is in Kamrup, Assam, India.
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.50 Cr.
The company currently has active open charges totaling ₹18.10 Cr.
Company Details
-
Location
Kamrup, Assam, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U15490AS2020PTC020689
-
Company No.
020689
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Nov 2020
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Shillong
Industry
Who are the key members and board of directors at Brahmaputra Biochem Bottling?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Karansingh Arora
|
Director | 09-Nov-2020 | Current |
|
Arjun Arora
|
Director | 09-Nov-2020 | Current |
Financial Performance of Brahmaputra Biochem Bottling.
Brahmaputra Biochem Bottling Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 2133.44% increase. The company also saw a substantial fall in profitability, with a 88.05% decrease in profit. The company's net worth observed a substantial decline by a decrease of 66.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Brahmaputra Biochem Bottling?
In 2023, Brahmaputra Biochem Bottling had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹18.10 Cr
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 18.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Feb 2021 | Axis Bank Limited | ₹18.10 Cr | Open |
How Many Employees Work at Brahmaputra Biochem Bottling?
Brahmaputra Biochem Bottling has a workforce of 20 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Brahmaputra Biochem Bottling, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Brahmaputra Biochem Bottling's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.